Abstract

Get full access to this article
View all access options for this article.
References
1.
Flachenecker
P
Stuke
K
Elias
W
. Multiple sclerosis registry in Germany: results of the extension phase 2005/2006 . Dtsch Arztebl Int 2008 ; 105 : 113 –119 .
2.
Kobelt
G
Kasteng
F
. Access to Innovative Treatin Multiple Sclerosis in Europe . 2009 .
http://www.comparatorreports.se/Access%20to%20MS%20treat20-%20October%202009.pdf
(Accessed April 2011 ).
3.
Kobelt
G
Berg
J
Lindgren
P
. Costs and quality of life of multiple sclerosis in Germany . Eur J Health Econ 2006 ; 7 Suppl 2 : S34 –S44 .
4.EUROSTAT . Harmonized indices for consumer prices [prc_hicp_aind] . 2011 .
http://appsso.eurostat.ec.europa.eu/nui/show.do?dataset=prc_hicp_aind&lang=en
(Accessed April 2011 ).
5.Fallpauschalen-Katalog . German Diagnostic Related Group (DRG) katalog . 2010 .
http://www.g-drg.de/cms/index.php/inek_site_de/G-DRG-System_2010/Fallpauschalen-Katalog
(Accessed April 2011 ).
6.Seniorenstift Schillerhöhe in Marbach am Neckar . 2011 .
http://www.seniorenstift-marbach.de/preise.html?PHPSESSID=malhu17ilf69eeeha7ciih4783
(Accessed April 2011 ).
7.Kassenärztliche Bundesvereinigung . National Association of Statutory Health Insurance Physicians . 2011 .
http://www.kbv.de/ebm2011/ebmgesamt.htm
(Accessed April 2011 .)
8.ROTE LISTE® Price list for prescribed medication. 2011 .
http://www.rote-liste.de/
(Accessed April 2011 ).
9.OECD . Income distribution - Inequality . 2011 .
http://stats.oecd.org/Index.aspx?DatasetCode=INEQUALITY
(Accessed April 2011 ).
10.OECD - Net income after taxes (national currency) . 2011 .
http://stats.oecd.org/OECDStat_Metadata/ShowMetadata.ashx?Dataset=AWCOMP&Lang=en&backtodotstat=false
(Accessed April 2011 ).
11.
Davison
A
Hinkley
D
. Bootstrap Methods and their Application . 8th ed. Cambridge Series in Statistical and Probabilistic Mathematics , 2006 .
12.
Ludbrook
J
. The Wilcoxon-Mann-Whitney test condemned . Br J Surg 1996 ; 83 : 136 –137 .
13.
Kobelt
G
Lindgren
P
Smala
A
. Costs and quality of life in multiple sclerosis. An observational study in Germany . Eur J Health Econ 2001 ; 2 : 60 –68 .
14.
Murphy
N
Confavreux
C
Haas
J
. Economic evaluation of multiple sclerosis in the UK, Germany and France . Pharmacoeconomics 1998 ; 13 : 607 –622 .
